Triple Hair Group与Akums Drugs & Pharmaceuticals合作，在印度推出脱发治疗Therapy-07，Akums资助试验并分享利润。 Triple Hair Group partners with Akums Drugs & Pharmaceuticals to introduce hair loss treatment Therapy-07 in India, with Akums financing trials and sharing profits.
Triple Hair Group，一家加拿大生物技术公司，与印度的Akums Drugs & Pharmaceuticals合作，在印度推出了其脱发治疗产品Therapy-07。 Triple Hair Group, a Canadian biotech firm, has partnered with India's Akums Drugs & Pharmaceuticals to introduce its hair loss treatment, Therapy-07, in India. Akums将资助监管费用,并监督第三阶段临床试验。 Akums will finance regulatory costs and oversee a Phase III clinical trial. 两家公司将平分利润，Triple Hair 将获得里程碑付款和特许权使用费。 The two companies will share profits equally, with Triple Hair receiving milestone payments and royalties. 这一合作的目的是在预计到2024年将超过30亿美元的市场上加强Akums皮肤科服务。 This collaboration aims to enhance Akums' dermatology offerings in a market projected to exceed $3 billion by 2024.